SL Science Holding Limited Ordinary Shares (SLBT) Stock Price, Financials & Summary | drillr

Skip to content

Sign in Sign up

Price chart

Sep 18Sep 23Sep 28Oct 1Oct 6Oct 9Oct 14Oct 19

Key dataOct 19, 2026

Open$1.56

From 52W high−86.12%

Volume12869.00

Market cap$857.96M

P/E (TTM)—

P/S (TTM)390.5x

Div yield—

Key dataOct 19, 2026

Open

$1.56

From 52W high

−86.12%

Volume

12869.00

Market cap

$857.96M

ValuationView details →

P/E (Fwd)

—

EV/EBITDA

−228.9x

P/E (TTM)

—

RSI (14)

37.0

MomentumView details →

1D Return

+0.00%

YTD Return

—

ValuationView details →

P/E (Fwd)

—

P/E (TTM)

—

EV/EBITDA

−228.9x

EV/Sales

390.0x

P/S (TTM)

390.5x

P/B (TTM)

375.7x

ProfitabilityView details →

Gross Margin

35.27%

Net Margin

−173.85%

EBITDA Margin

−170.39%

ROE (TTM)

−167.25%

ROA (TTM)

−135.59%

Asset Turnover

0.51x

GrowthView details →

Revenue YoY

—

EPS YoY

—

FCF YoY

—

Revenue CAGR 3Y

+58.11%

EPS CAGR 3Y

+100.00%

EBITDA YoY

—

MomentumView details →

1D Return

+0.00%

YTD Return

—

1Y Return

—

RSI (14)

37.0

vs 50D SMA

−27.56%

vs 200D SMA

—

Capital & dividendView details →

Debt/Equity

0.09x

Current Ratio

3.05x

Quick Ratio

3.05x

Div Yield

—

Div Rate

—

Div Growth 1Y

—

EarningsView details →

EPS (Actual)

—

EPS Surprise

—

Beats (12Q)

—

Next Q EPS Est

—

Avg Surprise (4Q)

—

Rev Surprise

—

Financials snapshotView financials →

Revenue (TTM)

—

Net Income (TTM)

—

Op. CF (TTM)

—

Latest newsMore news →

No recent news for SLBT.

Similar companies

CANbridge Pharmaceuticals Inc.01228.HK Odyssey Therapeutics, Inc.ODTX Rigel Pharmaceuticals, Inc.RIGL Aktis Oncology, Inc.AKTS Arbutus Biopharma CorporationABUS Jade Biosciences, Inc.JBIO Find similar companies →

Latest newsMore news →

No recent news for SLBT.